RICHARD A. DEREMEE, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In reference to the NIH Conference on vasculitis in the November issue (1), I wish to make a few comments and observations on the treatment of Wegener's granulomatosis and lymphomatoid granulomatosis.
Our experience with Wegener's granulomatosis includes more than 90 cases (2). Cytotoxic agents appear to provide a real advance in treatment. However, the role of glucocorticoids has been inappropriately downgraded. We have maintained patients in a quiescent state solely on prednisone therapy in the range of 60 to 100 mg on alternate days. These patients either could not tolerate or would not use cytotoxic agents for
DEREMEE RA. Granulomatosis Treatment. Ann Intern Med. ;90:436–437. doi: 10.7326/0003-4819-90-3-436_2
Download citation file:
Published: Ann Intern Med. 1979;90(3):436-437.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use